PNS manifests in approximately 16.8% to 43.6% of individuals diagnosed with HCC [5,12,13,14] and has been correlated with accelerated tumor advancement, the development of sizable tumors, the occurrence of multiple tumors within the liver, elevated serum levels of alpha-fetoprotein (AFP), and the invasion of HCC into the portal vein [8]. Here, AFP is linked to hepatocellular carcinoma.